Antitumor Effects of Intravenous Natural Killer Cell Infusion in an Orthotopic Glioblastoma Xenograft Murine Model and Gene Expression Profile Analysis

Despite standard multimodality treatment, containing maximum safety resection, temozolomide, radiotherapy, and a tumor-treating field, patients with glioblastoma (GBM) present with a dismal prognosis. Natural killer cell (NKC)-based immunotherapy would play a critical role in GBM treatment. We have...

Full description

Bibliographic Details
Main Authors:	Takayuki Morimoto, Tsutomu Nakazawa, Ryosuke Matsuda, Ryosuke Maeoka, Fumihiko Nishimura, Mitsutoshi Nakamura, Shuichi Yamada, Young-Soo Park, Takahiro Tsujimura, Ichiro Nakagawa
Format:	Article
Language:	English
Published:	MDPI AG 2024-02-01
Series:	International Journal of Molecular Sciences
Subjects:	glioblastoma NK cell murine orthotopic xenograft model
Online Access:	https://www.mdpi.com/1422-0067/25/4/2435

Similar Items

Therapeutic Anti-KIR Antibody of 1–7F9 Attenuates the Antitumor Effects of Expanded and Activated Human Primary Natural Killer Cells on In Vitro Glioblastoma-like Cells and Orthotopic Tumors Derived Therefrom
by: Ryosuke Maeoka, et al.
Published: (2023-09-01)

Natural Killer Cell-Based Immunotherapy against Glioblastoma
by: Takayuki Morimoto, et al.
Published: (2023-01-01)

Establishment of an efficient ex vivo expansion strategy for human natural killer cells stimulated by defined cytokine cocktail and antibodies against natural killer cell activating receptors
by: Tsutomu Nakazawa, et al.
Published: (2022-12-01)

Local administration of shikonin improved the overall survival in orthotopic murine glioblastoma models with temozolomide resistance
by: Ryosuke Maeoka, et al.
Published: (2023-10-01)

Ex Vivo Expanded and Activated Natural Killer Cells Prolong the Overall Survival of Mice with Glioblastoma-like Cell-Derived Tumors
by: Yoichi Shida, et al.
Published: (2021-09-01)

CRISPR-Cas9–Mediated TIM3 Knockout in Human Natural Killer Cells Enhances Growth Inhibitory Effects on Human Glioma Cells
by: Takayuki Morimoto, et al.
Published: (2021-03-01)

Resveratrol and Its Nanoformulation Attenuate Growth and the Angiogenesis of Xenograft and Orthotopic Colon Cancer Models
by: Thangirala Sudha, et al.
Published: (2020-03-01)

Tumor Growth Progression in Ectopic and Orthotopic Xenografts from Inflammatory Breast Cancer Cell Lines
by: Sara Caceres, et al.
Published: (2021-09-01)

Development and optimization of orthotopic liver metastasis xenograft mouse models in uveal melanoma
by: Takahito Sugase, et al.
Published: (2020-05-01)

Evaluation of Comprehensive Gene Expression and NK Cell-Mediated Killing in Glioblastoma Cell Line-Derived Spheroids
by: Takayuki Morimoto, et al.
Published: (2021-09-01)

Bulk RNA sequencing reveals the comprehensive genetic characteristics of human cord blood-derived natural killer cells
by: Takayuki Morimoto, et al.
Published: (2024-03-01)

High Engraftment and Metastatic Rates in Orthotopic Xenograft Models of Gastric Cancer via Direct Implantation of Tumor Cell Suspensions
by: Chao Wang, et al.
Published: (2024-02-01)

Establishment and characterization of in vivo orthotopic bioluminescent xenograft models from human osteosarcoma cell lines in Swiss nude and NSG mice
by: Maria Eugenia Marques da Costa, et al.
Published: (2018-03-01)

Generation of glioblastoma patient-derived organoids and mouse brain orthotopic xenografts for drug screening
by: Christian Moya Gamboa, et al.
Published: (2021-03-01)

Partial Substitution of Glucose with Xylitol Prolongs Survival and Suppresses Cell Proliferation and Glycolysis of Mice Bearing Orthotopic Xenograft of Oral Cancer
by: Yuraporn Sahasakul, et al.
Published: (2022-05-01)

Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis
by: Ken Kageyama, et al.
Published: (2017-06-01)

Establishment of an Endoscopy-Guided Minimally Invasive Orthotopic Mouse Model of Colorectal Cancer
by: Chen Chen, et al.
Published: (2020-10-01)

Establishment of an optimized orthotopic bladder cancer model in mice
by: Jinming Cai, et al.
Published: (2022-09-01)

An efficient feeder-free and chemically-defined expansion strategy for highly purified natural killer cells derived from human cord blood
by: Tsutomu Nakazawa, et al.
Published: (2023-12-01)

An Orthotopic Model of Uveal Melanoma in Zebrafish Embryo: A Novel Platform for Drug Evaluation
by: Chiara Tobia, et al.
Published: (2021-12-01)

Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse model
by: Tasuku Kiyuna, et al.
Published: (2018-08-01)

Development of a Novel Orthotopic Gastric Cancer Mouse Model
by: Wonyoung Kang, et al.
Published: (2021-01-01)

Magnetic resonance imaging-guided intracranial resection of glioblastoma tumors in patient-derived orthotopic xenografts leads to clinically relevant tumor recurrence
by: Anais Oudin, et al.
Published: (2024-01-01)

3D Multicellular Stem-Like Human Breast Tumor Spheroids Enhance Tumorigenicity of Orthotopic Xenografts in Athymic Nude Rat Model
by: Reza Bayat Mokhtari, et al.
Published: (2021-06-01)

CIS deletion by CRISPR/Cas9 enhances human primary natural killer cell functions against allogeneic glioblastoma
by: Tsutomu Nakazawa, et al.
Published: (2023-08-01)

Nanoparticle-Encapsulated Epirubicin Efficacy in the Inhibition of Growth of Orthotopic Ovarian Patient-Derived Xenograft in Immunocompromised Mice
by: Wioletta Kośnik, et al.
Published: (2024-01-01)

Frequent Infection of Human Cancer Xenografts with Murine Endogenous Retroviruses in Vivo
by: Asif Naseer, et al.
Published: (2015-04-01)

Development of syngeneic murine cell lines for use in immunocompetent orthotopic lung cancer models
by: Kyle Nolan, et al.
Published: (2020-08-01)

A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries
by: Omkara Lakshmi Veeranki, et al.
Published: (2019-12-01)

Human amniotic fluid mesenchymal stem cells attenuate pancreatic cancer cell proliferation and tumor growth in an orthotopic xenograft mouse model
by: Ying-Cheng Chen, et al.
Published: (2022-06-01)

Identification of Activated Protein Kinase Cα (PKCα) in the Urine of Orthotopic Bladder Cancer Xenograft Model as a Potential Biomarker for the Diagnosis of Bladder Cancer
by: Takahito Kawano, et al.
Published: (2021-08-01)

Novel Breast Cancer Brain Metastasis Patient-Derived Orthotopic Xenograft Model for Preclinical Studies
by: Masanori Oshi, et al.
Published: (2020-02-01)

Capability of Human Dendritic Cells Pulsed with Autologous Induced Pluripotent Stem Cell Lysate to Induce Cytotoxic T Lymphocytes against HLA-A33-Matched Cancer Cells
by: Tsutomu Nakazawa, et al.
Published: (2022-10-01)

Tumor Growth Suppression of Pancreatic Cancer Orthotopic Xenograft Model by CEA-Targeting CAR-T Cells
by: Osamu Sato, et al.
Published: (2023-01-01)

Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts
by: Yahaya A. Yabo, et al.
Published: (2024-04-01)

Exhaustion, rather than lack of infiltration and persistence, of CAR-T cells hampers the efficacy of CAR-T therapy in an orthotopic PDAC xenograft model
by: Yuta Takeuchi, et al.
Published: (2024-01-01)

Additive Antiproliferative and Antiangiogenic Effects of Metformin and Pemetrexed in a Non-Small-Cell Lung Cancer Xenograft Model
by: Jiun-Long Wang, et al.
Published: (2021-06-01)

Hyponatremia Promotes Cancer Growth in a Murine Xenograft Model of Neuroblastoma
by: Giada Marroncini, et al.
Published: (2023-11-01)

Metabolic and transcriptomic profiles of glioblastoma invasion revealed by comparisons between patients and corresponding orthotopic xenografts in mice
by: Cristina Cudalbu, et al.
Published: (2021-08-01)

An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatment
by: Doreen Huebner, et al.
Published: (2017-11-01)